MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma
MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma
复制标题
MiR-29c通过靶向TIAM1抑制鼻咽癌的侵袭和转移
DOI:
10.1016/j.canlet.2012.10.032
复制
发表时间:
2013-02-28
期刊:
影响因子:
9.7
通讯作者:
Ma, Jun
中科院分区:
文献类型:
--
作者:
Liu, Na;Tang, Ling-Long;Ma, Jun
Based on microarray analysis, we previously reported that miR-29c is significantly downregulated in nasopharyngeal carcinoma (NPC). However, little is known about the effect and molecular mechanisms of action of miR-29c deregulation during the development and progression of NPC. Quantitative RT-PCR demonstrated that miR-29c was significantly downregulated in NPC cell lines and clinical specimens. Wound healing, Transwell migration and lung metastasis assays demonstrated that ectopic expression of miR-29c inhibited NPC cell migration and invasion in vitro and suppressed the formation of lung metastases in vivo. T cell lymphoma invasion and metastasis 1 (TIAM1) was confirmed as a miR-29c target gene using luciferase reporter assays, quantitative RT-PCR and Western blotting. Ectopic expression of TIAM1 significantly promoted the migration and invasion of SUNE-1 cell line stably overexpressing miR-29c. The prognostic value of TIAM1 was analyzed in 217 NPC patients using immunohistochemistry. Strikingly, patients with high TIAM1 expression had poorer overall, disease-free and distant metastasis-free survival than patients with low TIAM1 expression. Furthermore, multivariate Cox regression analysis revealed that TIAM1 could serve as an independent prognostic factor in NPC. The newly identified miR-29c/TIAM1 pathway further elucidates the molecular mechanisms regulating invasion and metastasis in NPC, and may provide novel prognostic and treatment strategies for NPC patients. (C) 2012 Elsevier Ireland Ltd. All rights reserved.